Rein Therapeutics Inc (RNTX) — Financial Flexibility Index
Rein Therapeutics Inc (RNTX) has a Financial Flexibility Index of -0.23x as of March 2026. Free cash flow of $-3.42 Million (operating CF $-3.42 Million minus capex $0.00) represents 0% of total liabilities ($14.70 Million). Check tangible equity quality of Rein Therapeutics Inc to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Rein Therapeutics Inc Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Rein Therapeutics Inc across 11 annual periods. For the full cash flow conversion analysis, see RNTX operating cash flow.
Annual Financial Flexibility Index for Rein Therapeutics Inc (2015–2025)
Year-by-year free cash flow to debt coverage for Rein Therapeutics Inc. Explore how well can Rein Therapeutics Inc service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.67x | $-19.36 Million | $-19.36 Million | $7.24 Million | ▼ -78.1% |
| 2024 | -1.50x | $-22.29 Million | $-22.29 Million | $14.85 Million | ▼ -651.3% |
| 2023 | -0.20x | $-19.81 Million | $-19.81 Million | $99.12 Million | ▲ +97.3% |
| 2022 | -7.35x | $-24.86 Million | $-24.86 Million | $3.38 Million | ▼ -42.5% |
| 2021 | -5.16x | $-23.60 Million | $-23.75 Million | $4.58 Million | ▼ -5.2% |
| 2020 | -4.90x | $-20.47 Million | $-20.48 Million | $4.18 Million | ▼ -94.0% |
| 2019 | -2.52x | $-26.32 Million | $-26.47 Million | $10.43 Million | ▼ -15.1% |
| 2018 | -2.19x | $-23.50 Million | $-27.93 Million | $10.71 Million | ▲ +47.4% |
| 2017 | -4.17x | $-20.39 Million | $-20.53 Million | $4.89 Million | ▼ -3615.7% |
| 2016 | -0.11x | $-15.01 Million | $-15.01 Million | $133.83 Million | ▲ +3.2% |
| 2015 | -0.12x | $-11.62 Million | $-11.71 Million | $100.26 Million | — |